TET1 and acute lymphoblastic leukemia: Furthermore, a recent study reported overexpression of TET1 in T-cell acute lymphoblastic leukemia (T-ALL) and TET1-mediated promotion of leukemic growth to be dependent upon its catalytic ability to produce 5hmC (23), supporting the hypothesis that the DNA demethylation pathway represents an avenue for therapeutic action.